The Neurology of AIDSHoward E. Gendelman Neurological complications of progressive HIV-1 infection remain a common cause of morbidity even during widespread use of antiretroviral therapy (ART). Long-term resistance to ART, drug compliance, untoward drug side effects, a myriad of opportunistic infection, depression and other psychiatric disease manifestations, concomitant drug abuse, neuropathies, and an inability to clear viral reservoirs, explain, in large measure, disease progression and immune deterioration. These are associated with a number of psychiatric, muscle, nerve, infectious, as well as cognitive, behavioral, and motor disturbances seen in infected people. Fully updated from the previous two editions and replete with color images, The Neurology of AIDS, Third Edition covers each of these neurological complications and more with a focus on molecular and viral disease processes, cellular factors influencing viral replication therapeutic challenges, and the changing epidemiological patterns of disease. From basic science to clinical care, to epidemiological disease patters, The Neurology of AIDS is the only complete textbook available on AIDS neurology and the only one comprehensive enough to stand alone in each segment of study in brain disorders affected by the human immunodeficiency virus. It is an indispensable resource for students, resident physicians, practicing physicians, and for researchers and experts in the HIV/AIDS field. |
Contents
SECTION 1 HIV1 BIOLOGY AND IMMUNOLOGY | 1 |
SECTION 2 INNATE AND CELLULAR IMMUNITY AND NEUROGENESIS | 91 |
SECTION 3 BLOODBRAIN BARRIER AND HIV CNS ENTRY | 187 |
SECTION 4 CELLULAR AND VIRAL NEUROTOXICITY AND ABUSED DRUGS | 255 |
SECTION 5 ANIMAL MODELS | 363 |
SECTION 6 PERSONAL PERSPECTIVES IN LIVING WITH HIVAIDS | 461 |
SECTION 7 CLINICAL AND PATHOLOGIC MANIFESTATIONS OF DISEASE | 479 |
SECTION 8 PATHOGENESIS OF COMORBID CONDITIONS | 599 |
SECTION 9 DIAGNOSTICS AND BIOMARKERS | 761 |
SECTION 10 CHILDREN AND ADOLESCENTS | 873 |
SECTION 11 ANTIRETROVIRAL AND ADJUNCTIVE THERAPIES | 943 |
1015 | |
1099 | |
Other editions - View all
Common terms and phrases
activation addition adult AIDS alterations animals antiretroviral apoptosis associated astrocytes binding Biol blood blood-brain barrier brain causes CCR5 cellular changes chemokine chemokine receptor clinical complex contribute cultures CXCR4 cytokines damage decreased dementia demonstrated disease disorders drugs early effects encephalitis endothelial cells enhanced et al evidence expression factor function gene HAND HIV-1 infection host human immunodeficiency virus immune immunodeficiency virus type Immunol impairment important increased individuals induced inflammatory inhibition injury interactions involved leading levels lymphocytes macrophages major mechanisms mediated mice microglia monocytes morphine Nath Nature nervous system neurological neuronal Neurosci neurotoxicity observed oxidative pathways patients peripheral potential prevent primary production progression promoter protein receptor region regulation release replication reported Research response role showed shown signaling specific studies suggest therapy tion tissue transcription transgenic transport treatment vaccine viral Virol vitro vivo